WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
The Federal Trade Commission has released its second report digging into how the business practices of pharmacy benefit managers could be inflating drug costs in the U.S., in the latest and likely ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...
Dealbreaker on MSN12d
Pharmacy Benefit Managers Not Thrilled With FTC Report Finding Pharmacy Benefit Managers Raise Drug PricesThe pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback